to have involved subfunctionalization and later optimization in the regulatory regions of GAL1 and GAL3 in the lineage leading to S. cerevisiae. They found that replacing Gal3p with Gal1p resulted in decreased fitness relative to wild-type under inducing conditions. In addition, this strain does much better than a strain missing not only the GAL3 coding sequence but also the GAL3 promoter. Taken together, this suggests that GAL1 and GAL3 have also undergone subfunctionalization of their promoters, P GAL1 and P GAL3 . As a result of these changes, neither promoter is now a satisfactory substitute for the other. Expression of Gal1p from P GAL3 under inducing conditions is too low to permit efficient metabolism, and basal expression of Gal3p from P GAL1 is too low to permit efficient induction. P KlacGAL1 is also inferior to the modern S. cerevisiae P GAL1 . Expression of Gal1p from P KlacGAL1 under inducing conditions is about 50% that from P GAL1 , reducing fitness approximately 10%. These results suggest that adaptive mutations have occurred in P GAL1 , strengthening its inducibility.
To detail the molecular mechanisms involved in resolving the adaptive conflict, Hittinger and Carroll next tested the connection between fitness and the helical phasing of Gal4p binding sites within the S. cerevisiae and K. lactis GAL1 promoters. The importance of helical spacing of Gal4p binding sites in the activation of GAL1 has been well documented (Webster and Dickson, 1988) . In P GAL1 , the three core Gal4p sites are on the same side of the double helix; in P KlacGAL1 , they are on alternate sides. The authors tested the consequences of evolutionary changes in the binding side (phasing) by modifying P KlacGAL1 to the spacing of P GAL1 and found that both induced and noninduced expression increases. These results suggest that the adaptive conflict was resolved after duplication by subfunctionalization of the promoter and later optimization of galactose metabolism by changes in the phasing in P GAL1 ( Figure 1B) .
The actual ecological relevance of these mutations remains unclear. Hittinger and Carroll discovered that in K. lactis, the modified P KlacGAL1 outperforms the wild-type P KlacGAL1 at high galactose and lactose concentrations. In this species, limitations to the coinduction function are offset by a benefit to the galactokinase function. Reduced spacing may not be favored under the spectrum of conditions encountered by K. lactis in the wild, which could account for the arrangement of Gal4p binding sites in this species during 100 million years of divergence from the common ancestor. Understanding how gene duplication affects fitness under ecologically relevant conditions remains an important next step for this and other studies that examine the evolution of gene function. Retinoblastoma, a rare childhood cancer of the retina, has intrigued scientists for decades. Studies of retinoblastoma have provided pivotal insights into basic mechanisms underlying cancer formation. Retinoblastoma has served as a key model for tumor development caused by loss of tumor suppressor genes since the discovery of the retinoblastoma gene RB. The retinoblastoma protein pRB is a central gate-
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Hein te Riele 1, * keeper of the cell cycle governing the transition of cells from G 1 into S phase. The RB protein is helped by two related proteins, p107 and p130, collectively called "pocket proteins" because of their characteristic protein-interaction pocket. Together, they act as molecular switches turning off the activity of E2F transcription factors in response to growthrestricting conditions. Although this is now textbook knowledge (Weinberg, 2006) , the new work by Ajioka et al. (2007) on development of retinoblastoma in mice deficient for pocket proteins may provide another leap forward in our understanding of cancer.
Retinoblastoma was among the first cancers to be modeled in mice. However, early efforts at modeling retinoblastoma by targeting the Rb gene were a failure. Although children with one defective copy of RB invariably develop retinoblastoma following loss of the wild-type allele, no retinal abnormalities were observed in the corresponding mouse model. Instead, these animals suffered from a multiple endocrine neoplasia syndrome manifested by development of pituitary and thyroid tumors in which the wild-type Rb allele was lost. It was then discovered that retinoblastoma development in mice required inactivation of pRB plus another pocket protein, p107 or p130 (RobanusMaandag et al., 1998; Dannenberg et al., 2004) . In p107-or p130-deficient mice, removal of Rb in the retina (Chen et al., 2004; MacPherson et al., 2004; Zhang et al., 2004) caused formation of retinoblastoma tumors with a morphology resembling a specific subset of retinal cells-the amacrine cells that are interneurons of the inner nuclear layer. However, Ajioka et al. (2007) now demonstrate that inactivation of Rb in p130 −/− p107 +/− mice results in tumors with characteristics of another inner nuclear layer cell type of the retina, horizontal cells, which are also interneurons.
How do retinoblastomas arise? Retinal development has three distinct phases. First there is expansion of progenitor cells, then cell-cycle exit and differentiation of these cells into postmitotic precursors (also called "transit cells"), and finally terminal differentiation yielding the seven major retinal cell types. Two pathways have been proposed for retinoblastoma development. First, pocket-protein ablation may induce unscheduled expansion of an undifferentiated retinal progenitor cell that has retained the capacity of self-renewal and differentiation into specific cell types, such as inner nuclear layer cells (Zhang et al., 2004) . Alternatively, tumors may arise from cell-cycle re-entry of lineage-specific, postmitotic precursor cells (Chen et al., 2004) . The question is of interest, as it touches upon the heavily debated cancer stem cell hypothesis. If the first were true, the absence of pocket proteins would lead to increased division of poorly differentiated progenitors at the outer edge of the retina; however, this has not been observed (Chen et al., 2004) . Instead, it is the second pathway resulting in increased proliferation of differentiated precursor cell types that seems to occur. Apparently, in the absence of pocket proteins, differentiation into precursor cells proceeds normally despite continuing proliferation. However, these cells do not tolerate the absence of pocket proteins: rods, cones, ganglion cells, and bipolar cells of the retina undergo apoptotic cell death; in contrast, amacrine, horizontal, and Müller cells survive but stop proliferating (Chen et al., 2004; MacPherson et al., 2004) . As the latter cell types are found in full-blown retinoblastoma, it has been suggested (Chen et al., 2004 ) that alleviation of cell-cycle arrest rather than suppression of apoptosis is required for transformation of retinal cells lacking pocket proteins. The scenario thus emerging is that retinoblastoma in mice results from cell-cycle re-entry and subsequent proliferation of an intrinsically death-resistant precursor cell.
The new work by Ajioka et al. (2007) makes a strong case for the precursor cell hypothesis. These authors demonstrate that inactivation of Rb and p130 in the presence of only a single p107 allele in the retina leads to increased proliferation of a cell type bearing the characteristics of horizontal cells and located at the outer edge of the retina's inner nuclear layer. DNA synthesis and mitotic activity is observed in cells expressing markers specific for horizontal cells. Furthermore, cell bodies with condensed chromosomes (presumably undergoing mitosis) form synaptic processes and neuronal extensions called neurites that are characteristic of horizontal cells. The authors also show examples of horizontal cells undergoing cytokinesis while maintaining their characteristic neurites. Subsequently, after a brief period of indolence, aggressive metastatic tumors developed in which proliferating cells retained the characteristics of differentiated horizontal interneurons.
The new work has important implications. First, it challenges the widely held belief that differentiation and proliferation are incompatible processes. Furthermore, the new model in which differentiated neurons form aggressive metastatic tumors doesn't follow other findings that differentiation often inversely correlates with tumor aggressiveness. Second, these results and those of others dispute the prevailing hypothesis that growth of a differentiated cell tumor is driven by a small compartment of cancer stem cells. Loss of pocket proteins did not affect the proliferation and differentiation of retinal progenitor cells, and not a single proliferating progenitor cell has been found in retinoblastomas of either the amacrine or horizontal cell type (Chen et al., 2004; Ajioka et al., 2007) .
Two key questions that remain to be answered are why the inner nuclear layer neurons that lack pocket proteins stop proliferating initially, and what drives them back into the cell cycle? An explanation may come from Foijer et al. (2005) , who studied embryonic fibroblasts derived from mice lacking pocket proteins. In the absence of mito-gens, these cells died in large numbers. Blocking apoptosis, however, did not permit mitogen-independent growth; instead, these cells could not progress through the cell cycle, getting stuck predominantly in the G 2 phase. Interestingly, G 2 arrest was reversible and could be alleviated by either treatment with mitogens or inactivation of the tumor suppressor protein p53. Thus, mouse embryonic fibroblasts lacking pocket proteins and p53 can grow in the absence of mitogens, a hallmark of transformed cells. From the point of view of the retina, these observations suggest that pocket-protein-deficient inner nuclear layer neurons that are intrinsically apoptosis resistant are able to proliferate initially but then arrest in G 2 , perhaps because proliferation occurs ectopically, i.e., in the inner nuclear layer instead of in the outer edge of the retina. For clonal expansion and development of retinoblastoma, an additional event is required that alleviates G 2 arrest. Interestingly, a recent report shows that abrogation of the p53 pathway by overexpression of the p53 inhibitor MDMX strongly accelerates retinoblastoma development in mice (Laurie et al., 2006) . This was interpreted to indicate that suppression of apoptosis is an essential step in retinoblastoma development. However, the data of Foijer et al. (2005) leave open the possibility that loss of p53 function abolishes cell-cycle arrest. Thus, the model emerging is that retinoblastoma in mice requires two events: (1) loss of pocket proteins generating an increased pool of differentiated inner nuclear layer precursor cells in the retina (although with limited proliferation capacity) and (2) alleviation of cell-cycle arrest leading to the formation of a tumor composed of proliferating differentiated cells (Figure 1) .
Is the mouse a good model of human retinoblastoma? Although the genetics and histopathology of retinoblastomas in mice and humans may seem different (Nork et al., 1995) , it is quite possible that the basic mechanisms underlying retinoblastoma development are similar. Should this be confirmed, mouse models will prove valuable for testing new therapeutic approaches to defeat this devastating childhood cancer.
